MedPath

Investigation of the effect of administration of Metformin before surgery on controlling postoperative hyperglycemia in non-diabetic patients

Phase 3
Conditions
blood suger.
Registration Number
IRCT20111212008384N9
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
176
Inclusion Criteria

Non diabetic patients
ASA class I or II
Candidate for orthopedic surgery in Imam Reza Hospital of Mashhad during 1399 solar year
Ages 18 to 80 years

Exclusion Criteria

Prohibitions of metformin use, such as acute or chronic renal failure or injury, or a candidate for diagnostic procedures requiring the administration of a contrast agent before and 5 hours after surgery
Dissatisfaction
Allergy to metformin
Patients with ASA above grade II
Drug addicts
Uncomplicated surgical complication
Forcing to use hemodynamic support drugs at any stage of the study
Use non-general anesthesia to perform the procedure
Need re-surgical intervention in the first 24 hours
Diabetic people

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood suger. Timepoint: after surgery then every 6 hours for 24 hours. Method of measurement: Bs glocometr.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath